Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway/Experiment 1/Signature 1
From BugSigDB
Reviewed Marked as Reviewed by Atrayees on 2023-7-14
Source: supp fig 1B
Description: Supplementary Figure 1.Compositional differences in the gut microbiome are associated with responses to PD-1 antibody immunotherapy (B) Bar plot of compositional differences at genus level in the gut microbiome of three groups of mice by one-way ANOVA.
Abundance in Group 1: increased abundance in Coli
| NCBI | Quality Control | Links |
|---|---|---|
| Bacteroides | ||
| Ruminiclostridium | ||
| Parabacteroides | ||
| Erysipelotrichaceae |
Revision editor(s): Mary Bearkland, Atrayees
